Paolo Martelletti (P Martelletti)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 141

Top Venues

International journal of environmental research and public health

Expert review of neurotherapeutics

Toxins

The journal of headache and pain

Universita degli Studi di Roma La Sapienza Facolta di Medicina e Psicologia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita degli Studi di Roma La Sapienza Facolta di Medicina e Psicologia

Italy

Associate Professor :: Department of Clinical and Molecular Medicine

Publications

William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy (2024)
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert opinion on emerging drugs (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy 24 (5) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert opinion on emerging drugs 29 (1) (2024)
Alberto Raggi, Matilde Leonardi, Paolo Martelletti
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? Expert review of pharmacoeconomics & outcomes research 24 (4) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Lanfranco Pellesi, Paolo Martelletti
Situational prevention in migraine: are we doing the right thing? The journal of headache and pain 25 (1) (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy 24 (5) (2024)
Keiko Ihara, Tsubasa Takizawa, Narumi Watanabe, Jin Nakahara, Paolo Martelletti
Potential benefits and possible risks of CGRP-targeted multitherapy in migraine. Expert opinion on drug metabolism & toxicology 20 (1-2) (2024)
Alberto Raggi, Matilde Leonardi, Paolo Martelletti
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? Expert review of pharmacoeconomics & outcomes research (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Alberto Raggi, Matilde Leonardi, Paolo Martelletti
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? Expert review of pharmacoeconomics & outcomes research (2024)
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine. Toxins 16 (7) (2024)
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert opinion on emerging drugs (2024)
Lanfranco Pellesi, Paolo Martelletti
Situational prevention in migraine: are we doing the right thing? The journal of headache and pain 25 (1) (2024)
Carlo Baraldi, Dagmar Beier, Paolo Martelletti, Lanfranco Pellesi
The preclinical discovery and development of atogepant for migraine prophylaxis. Expert opinion on drug discovery (2024)
William David Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine. Expert review of neurotherapeutics (2024)
Carlo Baraldi, Dagmar Beier, Paolo Martelletti, Lanfranco Pellesi
The preclinical discovery and development of atogepant for migraine prophylaxis. Expert opinion on drug discovery 19 (7) (2024)
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine. Toxins 16 (7) (2024)
Keiko Ihara, Tsubasa Takizawa, Narumi Watanabe, Jin Nakahara, Paolo Martelletti
Potential benefits and possible risks of CGRP-targeted multitherapy in migraine. Expert opinion on drug metabolism & toxicology 20 (1-2) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy (2024)
Alberto Raggi, Matilde Leonardi, Paolo Martelletti
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? Expert review of pharmacoeconomics & outcomes research 24 (4) (2024)
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert opinion on emerging drugs 29 (1) (2024)
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine. Toxins 16 (7) (2024)
Claudio Tana, David Garcia Azorin, Francesco Cinetto, Cesare Mantini, Marco Tana, Massimo Caulo, Fabrizio Ricci, Paolo Martelletti, Francesco Cipollone, Maria Adele Giamberardino
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis. International journal of molecular sciences 24 (9) (2023)
Elena Gross, Elena Ruiz de la Torre, Paolo Martelletti
The Migraine Stigma Kaleidoscope View. Neurology and therapy (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Dilara Onan, Halime Arkan, Paolo Martelletti
The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability. Toxins 15 (12) (2023)
Claudio Tana, David Garcia Azorin, Francesco Cinetto, Cesare Mantini, Marco Tana, Massimo Caulo, Fabrizio Ricci, Paolo Martelletti, Francesco Cipollone, Maria Adele Giamberardino
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis. International journal of molecular sciences 24 (9) (2023)
Dilara Onan, Halime Arkan, Paolo Martelletti
The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability. Toxins 15 (12) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
William David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, Dilara Onan, Paolo Martelletti
Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert opinion on investigational drugs (2023)
Dilara Onan, Ozlem Ulger, Paolo Martelletti
Effects of Spinal Stabilization Exercises Delivered Using Telerehabilitation on Outcomes in Patients with Chronic Neck Pain: A Randomized Controlled Trial. Expert review of neurotherapeutics (2023)
William David Wells-Gatnik, Paolo Martelletti
Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal. Expert opinion on drug safety (2023)
Tsubasa Takizawa, Keiko Ihara, Shunsuke Uno, Seiya Ohtani, Narumi Watanabe, Noboru Imai, Jin Nakahara, Satoko Hori, David Garcia-Azorin, Paolo Martelletti
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review. Expert opinion on drug metabolism & toxicology (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Dilara Onan, Halime Arkan, Paolo Martelletti
The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability. Toxins 15 (12) (2023)
Claudio Tana, Francesco Cipollone, Maria Adele Giamberardino, Paolo Martelletti
New drugs targeting calcitonin gene-related peptide for the management of migraines. Expert opinion on emerging drugs (2023)
Dilara Onan, Halime Arkan, Paolo Martelletti
The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability. Toxins 15 (12) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
Dilara Onan, Samaira Younis, William David Wellsgatnik, Fatemeh Farham, Saulius Andruškevičius, Ana Abashidze, Asel Jusupova, Yuriy Romanenko, Oxana Grosu, Meerimgul Zamirbekovna Moldokulova, Ulkar Mursalova, Saida Saidkhodjaeva, Paolo Martelletti, Sait Ashina
Debate: differences and similarities between tension-type headache and migraine. The journal of headache and pain 24 (1) (2023)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome. Journal of comparative effectiveness research (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, Christian Lampl, Paolo Martelletti
New Migraine Drugs for Older Adults. Drugs & aging (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
William David Wells-Gatnik, Paolo Martelletti
Gepants in the acute management of migraine. Pain management (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Dilara Onan, Ozlem Ulger, Paolo Martelletti
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial. Expert review of neurotherapeutics (2023)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Andrew Blumenfeld, Aud Nome Dueland, Stefan Evers, Bronwyn Jenkins, Paolo Martelletti, Katherine Sommer
Practical Insights on the Identification and Management of Patients with Chronic Migraine. Pain and therapy 11 (2) (2022)
Enrico Bentivegna, Silvia Di Meo, Anita Carriero, Nadia Capriotti, Alberto Barbieri, Paolo Martelletti
Access to COVID-19 Vaccination during the Pandemic in the Informal Settlements of Rome. International journal of environmental research and public health 19 (2) (2022)
Dilara Onan, William David Wells-Gatnik, Paolo Martelletti
Reaching the Nadir of Medication Overuse in Chronic Migraine. International journal of environmental research and public health 19 (22) (2022)
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina I Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil-Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M Boucherie, Patricia Pozo-Rosich, Margarita Sanchez Del Rio, Alexandra Jean Sinclair, Antoinette MaassenVanDenBrink, Uwe Reuter
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. The journal of headache and pain 23 (1) (2022)
Claudia Altamura, Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, A M Miscio, A Santoro, Alicia Alpuente, A Russo, M Silvestro, Sabina Cevoli, Nicoletta Brunelli, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, I Frattale, K Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, E Filatova, Nina V Latysheva, A Gryglas-Dworak, Marcin Straburzyński, C Butera, B Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco, Fabrizio Vernieri
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study. Journal of neurology (2022)
Enrico Bentivegna, Cristina Tassorelli, Roberto De Icco, Grazia Sances, Paolo Martelletti
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes. Expert review of neurotherapeutics 22 (3) (2022)
Fidel Dominique Festin Ambat, Enrico Bentivegna, Paolo Martelletti
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (3) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Martina Cacciatore, Alberto Raggi, Andrea Pilotto, Viviana Cristillo, Erika Guastafierro, Claudia Toppo, Francesca Giulia Magnani, Davide Sattin, Arianna Mariniello, Fabiola Silvaggi, Stefano Cotti Piccinelli, Nicola Zoppi, Giulio Bonzi, Stefano Gipponi, Ilenia Libri, Michela Bezzi, Paolo Martelletti, Matilde Leonardi, Alessandro Padovani
Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis. International journal of environmental research and public health 19 (7) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Alberto Raggi, Matilde Leonardi, Simona Sacco, Paolo Martelletti
Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity. Pain and therapy 11 (2) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Farzaneh Allahdinian Hesaruiyeh, Saeed Rajabi, Mohadeseh Motamed-Jahromi, Mohammad Sarhadi, Michelle L Bell, Razieh Khaksefidi, Somayeh Sarhadi, Leili Mohammadi, Kamal Dua, Amin Mohammadpour, Paolo Martelletti
A Pilot Study on the Association of Lead, 8-Hydroxyguanine, and Malondialdehyde Levels in Opium Addicts' Blood Serum with Illicit Drug Use and Non-Addict Persons. International journal of environmental research and public health 19 (15) (2022)
Paolo Martelletti, Enrico Bentivegna
Insights into headache 2022. Expert review of neurotherapeutics 22 (2) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Enrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, Silvia Galastri, Francesco Baldari, Francesco Scarso, Piera A Lamberti, Paolo Martelletti
Recently approved and emerging drug options for migraine prophylaxis. Expert opinion on pharmacotherapy 23 (11) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
William David Wells-Gatnik, Fidel Dominique Festin Ambat, Paolo Martelletti
Hesitancies in primary headaches treatments. Expert review of neurotherapeutics 22 (9) (2022)
Silvia Benemei, Enrico Bentivegna, Paolo Martelletti
Positioning the new drugs for migraine. Expert opinion on drug metabolism & toxicology 18 (1) (2022)
Paolo Martelletti, Martina Curto
Unmet needs for migraine. Current medical research and opinion 37 (11) (2021)
Michelangelo Luciani, Andrea Negro, Valerio Spuntarelli, Enrico Bentivegna, Paolo Martelletti
Evaluating and managing severe headache in the emergency department. Expert review of neurotherapeutics 21 (3) (2021)
Paolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, Enrico Bentivegna
Deprescribing in migraine. Expert opinion on drug safety 20 (6) (2021)
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Alicia Alpuente, Antonio Russo, Marcello Silvestro, Sabina Cevoli, Nicoletta Brunelli, Fabrizio Vernieri, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, Katharina Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, Elena Filatova, Nina V Latysheva, Anna Gryglas-Dworak, Marcin Straburzyński, Calogera Butera, Bruno Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients. Pain and therapy 10 (2) (2021)
Marcin Straburzyński, Anna Gryglas-Dworak, Magdalena Nowaczewska, Eliza Brożek-Mądry, Paolo Martelletti
Etiology of 'Sinus Headache'-Moving the Focus from Rhinology to Neurology. A Systematic Review. Brain sciences 11 (1) (2021)
Enrico Bentivegna, Michelangelo Luciani, Francesco Scarso, Clara Bruscia, Dario Chiappino, Emanuele Amore, Gabriele Nalli, Paolo Martelletti
Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert review of neurotherapeutics (2021)
Paolo Martelletti, Todd J Schwedt, Pamela Vo, Daniela Ritrovato, Margaret C Reilly, Mariantonietta Naclerio, Pallavi Ranjan, Joern Kleebach, Parth Joshi
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey. Journal of medical economics 24 (1) (2021)
Licia Grazzi, Claudia Toppo, Domenico D'Amico, Matilde Leonardi, Paolo Martelletti, Alberto Raggi, Erika Guastafierro
Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches. International journal of environmental research and public health 18 (4) (2021)
Enrico Bentivegna, Michelangelo Luciani, Vincenzo Paragliola, Francesco Baldari, Piera A Lamberti, Giulia Conforti, Valerio Spuntarelli, Paolo Martelletti
Recent advancements in tension-type headache: a narrative review. Expert review of neurotherapeutics 21 (7) (2021)
Enrico Bentivegna, Michelangelo Luciani, Luca Arcari, Iolanda Santino, Maurizio Simmaco, Paolo Martelletti
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study. International journal of environmental research and public health 18 (3) (2021)
Paolo Martelletti, Martina Curto
Cluster Headache is Still Lurking in the Shadows. Pain and therapy 10 (2) (2021)
Paolo Martelletti, E Bentivegna, V Spuntarelli, M Luciani
Long-COVID Headache. SN comprehensive clinical medicine (2021)
Valerio Spuntarelli, Andrea Negro, Michelangelo Luciani, Enrico Bentivegna, Paolo Martelletti
Eptinezumab for the treatment of migraine. Expert opinion on biological therapy 21 (8) (2021)
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Alicia Alpuente, Antonio Russo, Marcello Silvestro, Sabina Cevoli, Nicoletta Brunelli, Fabrizio Vernieri, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, Ilaria Frattale, Katharina Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, Elena Filatova, Nina V Latysheva, Anna Gryglas-Dworak, Marcin Straburzynski, Calogera Butera, Bruno Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study. Pain and therapy 10 (1) (2021)
Anna K Eigenbrodt, Håkan Ashina, Sabrina Khan, Hans-Christoph Diener, Dimos D Mitsikostas, Alexandra Jean Sinclair, Patricia Pozo-Rosich, Paolo Martelletti, Anne Ducros, Michel Lantéri-Minet, Mark Braschinsky, Margarita Sanchez Del Rio, Oved Daniel, Aynur Ozge, Ayten Mammadbayli, Mihails Arons, Kirill Skorobogatykh, Vladimir Romanenko, Gisela M Terwindt, Koen Paemeleire, Simona Sacco, Uwe Reuter, Christian Lampl, Henrik Winther Schytz, Zaza Katsarava, Timothy J Steiner, Messoud Ashina
Diagnosis and management of migraine in ten steps. Nature reviews. Neurology 17 (8) (2021)
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, Ottavia De Luca, Fabiola Cipolla, Luana Lionetto, Maurizio Simmaco, Paolo Martelletti
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. Journal of clinical medicine 10 (7) (2021)
Matilde Leonardi, Licia Grazzi, Domenico D'Amico, Paolo Martelletti, Erika Guastafierro, Claudia Toppo, Alberto Raggi
Global Burden of Headache Disorders in Children and Adolescents 2007-2017. International journal of environmental research and public health 18 (1) (2020)
Andrea Negro, Valerio Spuntarelli, Paolo Sciattella, Paolo Martelletti
Rapid referral for headache management from emergency department to headache centre: four years data. The journal of headache and pain 21 (1) (2020)
Andrea Negro, Paolo Martelletti
Novel synthetic treatment options for migraine. Expert opinion on pharmacotherapy 22 (7) (2020)
Paolo Martelletti
"Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies. Pain and therapy 9 (2) (2020)
Paolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, Valerio Spuntarelli
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate. SN comprehensive clinical medicine (2020)
Luigi Martelletti, Paolo Martelletti
Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor. SN comprehensive clinical medicine (2020)
Antonio Del Casale, Stefano Ferracuti, Alessio Mosca, Leda Marina Pomes, Federica Fiaschè, Luca Bonanni, Marina Borro, Giovanna Gentile, Paolo Martelletti, Maurizio Simmaco
Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms. International journal of environmental research and public health 17 (18) (2020)

Paolo Martelletti.css-eqlu8i{font-size:small;padding-left:4px;} (P Martelletti)

Publication Activity (10 Years)

Top Topics

Top Venues

Paolo Martelletti (P Martelletti)